Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

An elderly man with serious medical issues has been reported missing on Houston’s northside. Judas Edmond, 79, was last seen ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

Montana State University Extension has released volume two of a magazine on Alzheimer’s disease and related dementias. The ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

UW-Madison said reductions in NIH funding will "ultimately harm the livelihoods of real people across Wisconsin and the ...

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...